About
We are an awesome team working on improving the
health of both patients and nurses.
-
- Micael Törnblom, CEO and Founder CYTO365
-
- Ida Virtala, Product Manager RondelO IV-set at CYTO365
-
- Patrik Gerenmark, R&D Specialist at CYTO365
-
- Mats Dörring, Head of Board at CYTO365
-
- Arne Nilsson, Investor and Boardmember CYTO365
-
- Olle Nilsson, Investor and Boardmember CYTO365
-
- Håkan Svenberg, Investor and Boardmember CYTO365
-
- Fredrik Lüning, Boardmember
-
- Linda Berndtsson, QARA and Boardmember at CYTO365
The company
CYTO365 AB is a small startup company that is already ten years old with global ambitions. After a long Take-Off run the first product will be launched shortly. It is an aim that RondelO™ will become the new standard component within infusion therapy for drugs that should be given in sequence.
We see a rapid expansion this year and we are always looking to connect with more enthusiastic people within this field.
Currently we want You that has experience in;
Patents
We invests heavily in our patent portfolio and hold multiple approved patents worldwide within infusion technology covering about 50% of worlds population.